Experimental evidence suggests that circUBE2G1-99aa inhibits GC cell proliferation, potentially through binding to the ENO1 enzyme and modulating the ENO1/PI3K/AKT pathway, thereby suppressing glycolysis and altering tumor metabolism. The gene discussed is AKT1; the disease is neoplasm.